Similar Articles
1281 Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
1282 Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?
1283 Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
1284 Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease
1285 Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma
1286 Aflatoxins, hepatocellular carcinoma and public health
1287 Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function
1288 Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients
1289 Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies
1290 Management of small hepatocellular carcinoma in cirrhosis: Focus on portal hypertension
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA